Northeastern University · 6 hours ago
BioNTech-Health Economics and Outcomes Research (HEOR) Postdoctoral Research Fellow
Northeastern University is offering a two-year Health Economics and Outcomes Research (HEOR) fellowship in collaboration with BioNTech, a biotechnology company focused on developing cancer therapeutics and vaccines. The fellowship aims to prepare Pharm.D. graduates to understand and communicate the value of BioNTech's products through hands-on experience in various therapeutic areas, including oncology and infectious diseases.
Education
Responsibilities
Work on products across the Oncology and Infectious disease therapeutic areas at BioNTech
Learn through hands-on experience and understand how global HEOR provides strategic inputs to address the specific value challenges for each individual therapy
Be fully integrated with the cross-functional environment (Medical Affairs, Market Access, Commercial, Biostatistics, Regulatory, Safety, Clinical Development and Clinical Operations) and work collaboratively to assess the value of the asset throughout its lifecycle
Support and learn to lead global HEOR studies which span across the key scientific pillars of Health Economics including
Patient-focused drug development including patient-reported outcomes as key measures in clinical trials, Patient’s Voice, and associated regulatory interactions
Real-world evidence generation and analysis to identify unmet needs and inform comparative effectiveness, global epidemiology (including race, ethnicity, age, sex) to support regulatory interactions and disease education & awareness
Network meta-analysis: indirect and mixed treatment comparisons (ITC/MTC)
Health economic models (cost effectiveness analysis [global and country adaptations], and global & country adaptations of budget impact analysis), and target patient population tools (US intended use and ex-US target patient population)
Global HEOR launch activities
In support of US launch – pre-approval information exchange (PIE) tools and post-approval value tools
Early advice/health authority interactions and reimbursement dossier development
Joint clinical assessment (JCA) and global value dossier development
Co-author abstracts, presentations, and manuscripts to clinical conferences (e.g., ASCO/ESMO), health economic conferences (e.g., ISPOR/AMCP), and peer-reviewed journals
Support the initiation and implementation of HEOR activities including value and evidence generation plan (VEG-P), RFP/SOW/contracting/invoicing, manage, operationalize, update publication plan and vendor interactions
Manage HEOR external facing materials development via company systems (e.g., Veeva Medcomms/PromoMats)
Working towards a Masters in HEOR during the fellowship is highly encouraged
Qualification
Required
Doctor of Pharmacy degree from an ACPE-accredited institution
Eligible for pharmacist licensure in the State of Massachusetts
Excellent oral and written communication skills
Strong time management and leadership abilities
Ability to work independently and take initiative on a variety of projects at both the industry site and Northeastern
Northeastern University will not provide H1-B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or in the future. Furthermore, the successful applicant must be able to maintain valid work authorization in the United States throughout the entire appointment without Northeastern University's sponsorship for a visa
Preferred
Advanced degree (PhD/ScD) preferred in related field including; Public Health-Health Policy & Management/Health Services Research/Epidemiology/Outcomes Research/Health Economics, Economics/Econometrics, Psychometrics, Statistics/Biostatistics, Pharmacoeconomics/Pharmacy Administration
Working towards a Masters in HEOR during the fellowship is highly encouraged
Benefits
Medical
Vision
Dental
Paid time off
Tuition assistance
Wellness & life
Retirement-
Commuting & transportation
Company
Northeastern University
Founded in 1898, Northeastern is a global research university with a distinctive, experience-driven approach to education and discovery.
Funding
Current Stage
Late StageRecent News
2024-01-06
Alfred P. Sloan Foundation
2023-10-30
Company data provided by crunchbase